Dr Agarwal'S Eye HospitalBOM:526783 -0.58%94 EBITDA Margin % is 29.42% as of Mar. 2026, which is 4% above its 10-year median of 28.18. GuruFocus rates BOM:526783 with a GF Score™ of 94/100 and a GF Value™ of ₹5,310.81 (Fairly Valued). The stock has 3 warning signs investors should review. Among 668 Healthcare Providers & Services companies, Dr Agarwal'S Eye Hospital ranks better than 92.07% on this metric.
Dr Agarwal'S Eye Hospital (BOM:526783) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Dr Agarwal'S Eye Hospital EBITDA Margin % Related Terms
Dr Agarwal'S Eye Hospital EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:526783 vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Dr Agarwal'S Eye Hospital's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dr Agarwal'S Eye Hospital EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Dr Agarwal'S Eye Hospital's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Dr Agarwal'S Eye Hospital's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dr Agarwal'S Eye Hospital (BOM:526783) has a EBITDA Margin % of 29.42% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Dr Agarwal'S Eye Hospital and its competitors. This is near median its historical median of 28.18. Over the past decade, Dr Agarwal'S Eye Hospital's EBITDA Margin % has ranged from 15.52 to 32.20. According to the industry distribution chart, Dr Agarwal'S Eye Hospital ranks #53 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 7.9%.
Is Dr Agarwal'S Eye Hospital's EBITDA Margin % too high?
Dr Agarwal'S Eye Hospital's current EBITDA Margin % of 29.42% is near median its 10-year median of 28.18. Over the past 10 years, this metric has ranged from a low of 15.52 to a high of 32.20. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. Dr Agarwal'S Eye Hospital's value of 29.42% is 188.1% above this industry median. Based on the distribution chart, Dr Agarwal'S Eye Hospital ranks #53 out of 668 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Dr Agarwal'S Eye Hospital has a GF Score™ of 94/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Dr Agarwal'S Eye Hospital's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Dr Agarwal'S Eye Hospital ranks #53 out of 668 companies for EBITDA Margin %. This places Dr Agarwal'S Eye Hospital in the top 8% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 10.21. Dr Agarwal'S Eye Hospital's value of 29.42% is 188.1% above this benchmark. Historically, Dr Agarwal'S Eye Hospital's own EBITDA Margin % has ranged from 15.52 to 32.20 over the past decade. While the company's 10-year median is 28.18 vs. the industry median of 10.21, Dr Agarwal'S Eye Hospital has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dr Agarwal'S Eye Hospital's current EBITDA Margin % of 29.42% is 188.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Dr Agarwal'S Eye Hospital and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dr Agarwal'S Eye Hospital's current EBITDA Margin % is 29.42%, which is near median its own 10-year median of 28.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr Agarwal'S Eye Hospital stock overvalued right now?
Based on GuruFocus' analysis, Dr Agarwal'S Eye Hospital (BOM:526783) is currently considered Fairly Valued. The stock's GF Value™ is ₹5,310.81, compared to a current price of ₹5,041.05 — trading 5.1% below its estimated fair value. The current EBITDA Margin % is 29.42%, which is near median its 10-year median of 28.18 and 188.1% above the Healthcare Providers & Services industry median of 10.21. Dr Agarwal'S Eye Hospital's overall GF Score™ is 94/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Dr Agarwal'S Eye Hospital (BOM:526783), the current EBITDA Margin % is 29.42% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dr Agarwal'S Eye Hospital (BOM:526783) Overvalued in 2026?
Based on GuruFocus' analysis, Dr Agarwal'S Eye Hospital stock appears to be undervalued.
The current stock price of ₹5,041.05 is trading 5.1% below its estimated GF Value™ of ₹5,310.81.
GuruFocus considers Dr Agarwal'S Eye Hospital to be Fairly Valued.
Key valuation signals for BOM:526783:
EBITDA Margin %: 29.42% (near median its 10-year median of 28.18)
GF Value™: ₹5,310.81 vs. price of ₹5,041.05 (5.1% below fair value)
Industry Position: 188.1% above the Healthcare Providers & Services median (#53 of 668)
No single metric tells the full story. See the BOM:526783 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dr Agarwal'S Eye Hospital Ltd is a provider of eye care and related services. The company is predominantly engaged in running, owning and managing eye care hospitals, opticals, pharmacies, and related services. It operates across various locations in India and provides solutions like Refractive Surgery, Lasik Surgery, Oculoplasty, Laser Cataract Surgery, and SMILE Eye Surgery among others.
94GF Score
Get the complete analysis for BOM:526783
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:526783 has been successfully added to your 
